WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Using Neuromodulation to Improve Parkinson's Disease

Not Applicable

Withdrawn

Conditions: Parkinson Disease

Interventions: Device: Experimental 1
Device: Experimental 2

First Posted Date: 2020-07-30

Last Posted Date: 2020-10-14

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT04493697

Locations: 🇺🇸
Wake Forest Health Sciences, Winston-Salem, North Carolina, United States

Local Consolidative Radiotherapy for Oligoprogressive in Non-small Cell Lung Carcinoma

Phase 2

Withdrawn

Conditions: Non Small Cell Lung Cancer
Oligoprogressive

Interventions: Radiation: Local consolidative radiation therapy
Drug: Standard of care radiation therapy

First Posted Date: 2020-07-24

Last Posted Date: 2022-05-04

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT04485026

An Internet-based Program to Help Cancer Survivors Manage Pain

Not Applicable

Recruiting

Conditions: Cancer

Interventions: Behavioral: Internet-based pain coping skills program

First Posted Date: 2020-07-08

Last Posted Date: 2025-01-06

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 456

Registration Number: NCT04462302

Locations: 🇺🇸
Rice Memorial Hospital, Willmar, Minnesota, United States
🇺🇸
Kaiser Permanente-Oakland, Oakland, California, United States
🇺🇸
Kaiser Permanente-Stockton, Stockton, California, United States

and more 138 locations

Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition

Phase 2

Active, not recruiting

Conditions: Advanced Head and Neck Squamous Cell Carcinoma
Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck
Metastatic Head-and-neck Squamous-cell Carcinoma
Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck
Locally Advanced Head and Neck Squamous Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma

Interventions: Drug: Pembrolizumab (immunotherapy)
Radiation: Quad-shot palliative radiotherapy

First Posted Date: 2020-07-01

Last Posted Date: 2024-10-16

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 21

Registration Number: NCT04454489

Locations: 🇺🇸
Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States

Esophagogastric Junction Distensibility During Hiatal Hernia Repair

Not Applicable

Recruiting

Conditions: Esophagogastric Junction Distensibility
Hiatal Hernia

Interventions: Procedure: Surgeon unblinded
Device: EndoFLIP 1.0 System EF-100

First Posted Date: 2020-06-29

Last Posted Date: 2024-07-25

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 50

Registration Number: NCT04450628

Locations: 🇺🇸
Atrium Health - Carolinas Medical Center, Charlotte, North Carolina, United States

Ambient Lighting During Colonoscopy and Its Effect on Adenoma Detection Rate and Eye Fatigue

Not Applicable

Completed

Conditions: Colorectal Cancer Screening
Colon Adenomatous Polyp

Interventions: Other: Ambient lighting
Other: Low lighting

First Posted Date: 2020-06-22

Last Posted Date: 2024-10-04

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 1109

Registration Number: NCT04441242

Locations: 🇺🇸
Advocate Lutheran General Hospital, Park Ridge, Illinois, United States

Validate a Pharmacodynamic Model of Oxytocin for Peripheral Analgesic Effects

Phase 2

Not yet recruiting

Conditions: Osteoarthritis, Knee

Interventions: Drug: Oxytocin

First Posted Date: 2020-06-17

Last Posted Date: 2024-04-26

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 26

Registration Number: NCT04435704

Locations: 🇺🇸
Wake Forest Baptist Health, Winston-Salem, North Carolina, United States

Apply the PD Model of Peripheral Oxytocin Action to a Multimodal Stimulus

Phase 2

Withdrawn

Conditions: Pain, Chronic

Interventions: Drug: Oxytocin
Drug: Placebo

First Posted Date: 2020-06-16

Last Posted Date: 2024-10-26

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 30

Registration Number: NCT04433741

Locations: 🇺🇸
Wake Forest Baptist Health, Winston-Salem, North Carolina, United States

Generate a Pharmacodynamic Model of Oxytocin for Peripheral Analgesic Effects

Phase 2

Recruiting

Conditions: Osteoarthritis, Knee

Interventions: Drug: Oxytocin

First Posted Date: 2020-06-16

Last Posted Date: 2024-02-28

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 38

Registration Number: NCT04431206

Locations: 🇺🇸
Wake Forest Baptist Health, Winston-Salem, North Carolina, United States

Estimate Serum Oxytocin PD Range in the Periphery

Phase 2

Withdrawn

Conditions: Osteoarthritis, Knee

Interventions: Drug: Oxytocin

First Posted Date: 2020-06-16

Last Posted Date: 2022-12-30

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT04431193

Locations: 🇺🇸
Wake Forest Baptist Health, Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy